Effect Of N-(4-Acetyl-1-piperazinyl)-p-fluorobenzamide Monohydrate (FK960), An Antidementia Drug With A Novel Mechanism Of Action, On Regional Cerebral Blood Flow And Glucose Metabolism In Aged Rhesus Macaques Studied With Positron Emission Tomography